Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Current and Projected Market Size of the Eylea Industry?
The market size of Eylea has seen significant growth in recent years. It’s expected to increase from $9.94 billion in 2024 to $10.51 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.7%. The market expansion during the previous period is credited to the increasing prevalence of diabetic macular edema (DME), competitive efficiency and safety measures, competition against other anti-VEGF therapies, the approval of several retinal conditions, and a shift towards intravitreal injections.
Strong expansion is projected for the eylea market in the coming years, with its value expected to reach “$13.64 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.7%.” Factors contributing to this predicted growth within the forecast period include new therapeutic indications, the emergence of biosimilar competition, increased awareness and diagnoses, real-world evidence, and post-market studies, coupled with a patient preference for less frequent injections. The forecast period also foresees key trends such as improvements in imaging technologies, the rise of telemedicine and remote monitoring, patient assistance schemes, progressions in drug delivery technologies, retinal imaging technologies, and clinical trials targeting new indications.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9155&type=smp
#Which Factors Are Currently Driving The Growth Of The Eylea Market?
The anticipated surge in ocular diseases is predicted to drive the growth of the Eylea market. Ocular diseases are eye disorders which impede the accurate function of the eyes and adversely impact vision clarity. These conditions often remain symptom-free until they have significantly progressed. Eylea is adept at treating such diseases including wet age-related macular degeneration (AMD) and glaucoma, conditions that cause harm to the retina or macula and subsequently, the eyesight. Eylea’s mechanism of action involves inhibiting a protein responsible for the formation of new and weaker blood vessels while also reducing the swelling in the retina attributed to a blood vessel blockage. As reported by BrightFocus Foundation, a US-based nonprofit involved in promoting research and backing for macular degeneration and glaucoma, in October 2022, the global glaucoma patient population was 80 million, with an expected escalation to over 111 million by 2040. This rise in ocular diseases is serving as a key driver for the Eylea market.
How Is The Global Eylea Market Structured In Terms Of Segments?
The eylea market covered in this report is segmented –
1) By Product: Prefilled Syringe Package, Vial Package
2) By Disorder: Wet Age-Related Macular Degeneration (AMD), Diabetic Retinopathy, Other Disorders
3) By Application: Hospitals, Retail Pharmacy, Other Applications
Subsegments:
1) By Prefilled Syringe Package: Single-Dose Prefilled Syringes, Multi-Dose Prefilled Syringes
2) By Vial Package: Single-Dose Vials, Multi-Dose Vials
Which Trends Are Redefining The Future Landscape Of The Eylea Industry?
In the eylea market, one emerging trend is the constant research and developments by the major industry players. Their top priority is to create advanced technical solutions. An example of this is Regeneron Pharmaceuticals, Inc., a biotechnology company from the US that produces medicine for serious diseases. They obtained US FDA approval in August 2023 for their Eylea HD (aflibercept) injection 8 mg. This product has been designed to help patients suffering from wet age-related macular degeneration (wAMD), diabetic macular edema (DME), and diabetic retinopathy (DR). The recommended administration for this drug begins with a period of once every four weeks for the first three months for all conditions mentioned. Subsequently, the schedule is adjusted to intervals of every eight to 16 weeks for wAMD and DME, and every eight to 12 weeks for diabetic retinopathy.
Who Are The Main Participants Shaping The Eylea Market Landscape?
Major companies operating in the eylea market include Regeneron Pharmaceuticals Inc., Bayer AG, Novartis AG, Roche Holding AG, Pfizer Inc., Amgen Inc., Sanofi S.A., AbbVie Inc., Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., GlaxoSmithKline plc, Biogen Inc., Alcon Inc., Johnson & Johnson, Eli Lilly and Company, Genentech Inc., AstraZeneca plc, Bristol-Myers Squibb Company, Samsung Bioepis Co. Ltd., Lupin Limited, Sun Pharmaceutical Industries Ltd., Zydus Cadila, Torrent Pharmaceuticals Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals LLC, Apotex Inc.
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/eylea-global-market-report
Which Region Currently Holds The Largest Share In The Eylea Market?
North America was the largest region in the eylea market in 2024. Asia-Pacific is expected to be the fastest-growing region in the eylea market during the forecast period. The regions covered in the eylea market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=9155&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model